特发性正常压力脑积水患者脑室腹腔分流置管的安全性:抗凝与非抗凝患者的比较
本研究回顾性分析了2018至2022年间接受分流术的234例60岁以上特发性正常压力脑积水(iNPH)患者,其中36例使用抗凝/抗血小板药物(不含阿司匹林)。使用抗凝/抗血小板药物的患者穿刺道出血发生率更高(11.1% vs 2.5%,P=0.03),但两组总体出血并发症发生率相似;脑室内出血及过度引流相关硬膜下积液发生率无显著差异。
要点
- 抗凝/抗血小板组穿刺道出血发生率11.1% vs 非抗凝组2.5%(P=0.03)。
- 两组脑室内出血及过度引流相关硬膜下积液发生率无显著差异,总体出血并发症发生率相似。
核心结论
- iNPH人群中抗凝及抗血小板药物使用常见,使用这些药物的患者脑室腹腔分流置管后穿刺道出血发生率更高,但总体出血并发症发生率相似。
研究设计与样本
- 回顾性研究,纳入2018至2022年间接受分流术的60岁以上iNPH患者,共234例,平均年龄75.22±6.04岁,男性占66.7%。
- 收集基线人口学资料、合并症(以改良衰弱指数和Charlson合并症指数量化)、抗凝/抗血小板药物使用(阿司匹林除外)、手术细节及并发症。
- 关注结局为术后出血和过度引流的发生。
- 36例使用抗凝/抗血小板治疗(阿司匹林除外),包括6例华法林、19例直接Xa抑制剂、10例氯吡格雷、1例氯吡格雷联合华法林。
- 70%的患者(164/234)单用阿司匹林或阿司匹林联合抗凝药或氯吡格雷。
主要发现
- 抗凝/抗血小板组平均Charlson合并症指数高于非抗凝组(2.67±1.87 vs 1.75±1.84;P=0.001)。
- 两组基线改良衰弱指数相似。
- 抗凝/抗血小板组穿刺道出血发生率高于非抗凝组(11.1% vs 2.5%;P=0.03)。
- 两组脑室内出血发生率无显著差异。
- 两组过度引流相关硬膜下积液发生率无显著差异。
关键数值与推荐
- 使用抗凝/抗血小板药物(阿司匹林除外)的患者穿刺道出血发生率为11.1%,未使用者为2.5%(P=0.03)。
- 抗凝/抗血小板组平均Charlson合并症指数为2.67±1.87,非抗凝组为1.75±1.84(P=0.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Many patients with idiopathic normal pressure hydrocephalus (iNPH) have medical comorbidities requiring anticoagulation that could negatively impact outcomes. This study evaluated the safety of ventriculoperitoneal shunt placement in iNPH patients on systemic anticoagulation versus those not on anticoagulation. METHODS: Patients >60 years of age with iNPH who underwent shunting between 2018 and 2022 were retrospectively reviewed. Baseline demographics, comorbidities (quantified by modified frailty index and Charlson comorbidity index), anticoagulant/antiplatelet agent use (other than aspirin), operative details, and complications were collected. Outcomes of interest were the occurrence of postoperative hemorrhage and overdrainage. RESULTS: A total of 234 patients were included in the study (mean age 75.22 ± 6.04 years; 66.7% male); 36 were on anticoagulation/antiplatelet therapy (excluding aspirin). This included 6 on Warfarin, 19 on direct Xa inhibitors, 10 on Clopidogrel, and 1 on both Clopidogrel and Warfarin. Notably, 70% of patients (164/234) used aspirin alone or combined with anticoagulation or clopidogrel. Baseline modified frailty index was similar between groups, but those on anticoagulant/antiplatelet therapy had a higher mean Charlson comorbidity index (2.67 ± 1.87 vs. 1.75 ± 1.84; P = 0.001). Patients on anticoagulants were more likely to experience tract hemorrhage (11.1 vs. 2.5%; P = 0.03), with no significant difference in the rates of intraventricular hemorrhage or overdrainage-related subdural fluid collection. CONCLUSIONS: Anticoagulant and antiplatelet agents are common in the iNPH population, and patients on these agents experienced higher rates of tract hemorrhage following ventriculoperitoneal shunt placement; however, overall hemorrhagic complication rates were similar.
引用
- Hamouda AM, Pennington Z, Shafi M, et al. Ventriculoperitoneal Shunt Placement Safety in Idiopathic Normal Pressure Hydrocephalus: Anticoagulated Versus Non-Anticoagulated Patients. World Neurosurg. 2024. PMID: 38604534. doi:10.1016/j.wneu.2024.04.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。